Ramiro Ribeiro

Chief Medical Officer, EyePoint Pharmaceuticals.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 30, 2026Sold 2,438 shares at $15.02 of EyePoint Pharmaceuticals²
Jun 30, 2026Sold 2,437 shares at $15.00 of EyePoint Pharmaceuticals²
Jun 30, 2026Exercised options 2,438 shares at $8.26 of EyePoint Pharmaceuticals²
Jun 30, 2026Exercised options 2,437 shares at $8.26 of EyePoint Pharmaceuticals²
Apr 17, 2026Sold 2,437 shares at $15.00 of EyePoint Pharmaceuticals³
Apr 17, 2026Exercised options 2,437 shares at $8.26 of EyePoint Pharmaceuticals³
Mar 4, 2026Sold 2,438 shares at $17.87 of EyePoint Pharmaceuticals⁴
Mar 4, 2026Exercised options 2,438 shares at $8.26 of EyePoint Pharmaceuticals⁴
Feb 17, 2026Sold 2,437 shares at $15.00 of EyePoint Pharmaceuticals⁵
Feb 17, 2026Exercised options 2,437 shares at $8.26 of EyePoint Pharmaceuticals⁵
Jan 5, 2026Sold 42,544 shares at $17.10 of EyePoint Pharmaceuticals⁶
Jan 5, 2026Exercised options 29,250 shares at $8.26 of EyePoint Pharmaceuticals⁶
Jan 3, 2026Shares withheld for tax 6,373 shares at $17.48 of EyePoint Pharmaceuticals⁷
Jan 3, 2026Exercised options 19,667 shares of EyePoint Pharmaceuticals⁷
Nov 11, 2025Sold 2,722 shares at $11.61 of EyePoint Pharmaceuticals⁸

The numbers on this page point here. Each one links to the record it came from.